WHO keeps mpox alert over West Africa outbreak
Mpox Remains a Global Health Concern: WHO Update The World Health Organization (WHO) has announced that mpox continues to be classified as an international health […]
Skip to content
You May Also Like:
Study finds association nights heart rate and later health problems
Sleep HRV as Early Predictor of Health Risks: A New Study A groundbreaking study from the University Hospital of Bern suggests that monitoring heart rate […]
Blood sugar control brain boost GLP1 drugs tied to less migraine pain
Diabetes Drug Shows Promise in Reducing Migraine Frequency Exciting news for migraine sufferers! A recent study presented at the European Academy of Neurology (EAN) Congress […]
Targeting Fusion Protein Shows Great Leukemia Outcome
Promising New Combination Therapy Identified for Challenging Diseases Researchers at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute have announced a significant breakthrough in […]
One psilocybin dose aids cancer sufferers fight depression
Hope for Cancer Patients: Psilocybin Therapy Shows Long-Term Depression Relief Groundbreaking research offers renewed hope for cancer patients battling depression. A single session of psilocybin-assisted […]
Use GLP1s First to Halt Heart Ailments ACC Suggests
American College of Cardiology Recommends Broader Use of Weight-Loss Drugs for Heart Health The American College of Cardiology (ACC) suggests that a significant number of […]
Stool transplant promising as initial therapy for C difficile disease
Fecal Transplant: A Powerful Alternative to Antibiotics for Severe Diarrhea A groundbreaking study has revealed that fecal microbiota transplantation (FMT), also known as a fecal […]